Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma - Contacts and Locations

Home

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

This study has been completed.

Study NCT00019721. Last updated on October 18, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00019721

Locations


United States, Maryland
	Surgery Branch
	Bethesda, Maryland, United States, 20892

Sponsors and Collaborators

NCI - Center for Cancer Research-Medical Oncology

Investigators


Study Chair:	Steven A. Rosenberg, MD, PhD	NCI - Surgery Branch